Vitamin K helps prevent osteoporosis.

  Low vitamin K intake is associated with bone loss and fractures in people with osteoporosis. And some research suggests that chronic warfarin, a vitamin K antagonist, decreases bone density.

  Several studies suggest that supplementation with a specific form of vitamin K called menaquinone might increase bone density and reduce the risk for fracture.

  But all of the fracture data comes out of Japan. And there is no reliable evidence that taking the form of vitamin K available in the U.S. and Canada, phytonadione, can reduce fracture risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote